Yes, 12.5% of revenues (not profit) might be the typical ball park for licensing royalties
The margins are typically very good on drug manufacturing, its the process of getting successful trials and regulatory approval that make commercial development so expensive.
KZA Price at posting:
$1.28 Sentiment: Hold Disclosure: Held
